SEPTInvestingStart Free

MED SCHEDULE 13G: SEC filing

Susquehanna Portfolio Strategies, LLC and Susquehanna Securities, LLC

Filed with the SEC on · accession 0001446580-26-000098

MED filed a SCHEDULE 13G (schedule 13g) with the SEC on Aug 14, 2026. Susquehanna Portfolio Strategies, LLC and Susquehanna Securities, LLC filed a joint Schedule 13G disclosing beneficial ownership of Medifast, Inc. common stock. The stock moved -0.3% by the first close after the filing.

Summary of the filing

Susquehanna Portfolio Strategies, LLC and Susquehanna Securities, LLC filed a joint Schedule 13G disclosing beneficial ownership of Medifast, Inc. common stock. The filing includes a joint filing agreement executed by both entities.

For details, click here →

Key details

IssuerMedifast, Inc.
Filer / beneficial ownerSusquehanna Portfolio Strategies, LLC
Filer / beneficial ownerSusquehanna Securities, LLC
Assistant secretary, susquehanna portfolio strategies, llcBrian Sopinsky
Secretary, susquehanna securities, llcBrian Sopinsky

How MED stock reacted

Close before

$11.48

Aug 13, 2026

First close after

-0.35%

$11.44

5 trading days

+1.22%

$11.62

Since filing

+11.59%

$12.81

✦ Ask GOAX AI about this filing — what it means for MED, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for MED?

Click here

Frequently asked questions

What did MED file with the SEC on Aug 14, 2026?

MED filed a SCHEDULE 13G (SEC filing). Susquehanna Portfolio Strategies, LLC and Susquehanna Securities, LLC filed a joint Schedule 13G disclosing beneficial ownership of Medifast, Inc. common stock. The filing includes a joint filing agreement executed by both entities.

How do I read a SCHEDULE 13G?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).

How did MED stock react to this filing?

MED closed at $11.48 before the filing and $11.44 on Aug 14, 2026 (-0.35%). Five trading days later: $11.62 (+1.22%).

Other MED SEC filings

Get alerts when MED files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
MED overviewMED analysisMED newsLatest SEC filings